Immunophenotype and increased presence of CD4+CD25+ regulatory T cells in patients with acute lymphoblastic leukemia

By          

Oncology Letters, Vol. 3, Iss. 2, 2012-01 ,pp. : 421-424

Spandidos Publications

Access to resources Recommend Favorite

Serum IL10, IL12 and circulating CD4+CD25high T regulatory cells in relation to long-term clinical outcome in head and neck squamous cell carcinoma patients

By            

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 833-839

Spandidos Publications

Access to resources Recommend Favorite

Telomere length of in vivo expanded CD4⁺CD25⁺ regulatory T-cells is preserved in cancer patients

By Wolf Dominik   Rumpold Holger   Koppelstätter Christian   Gastl Guenther   Steurer Michael   Mayer Gert   Gunsilius Eberhard   Tilg Herbert   Wolf Anna  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1198-1208

Springer Publishing Company

Access to resources Recommend Favorite

Functionally distinct subsets of CD4+ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 354-362

Spandidos Publications

Access to resources Recommend Favorite

Tumor-derived CD4⁺CD25⁺ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10

By Larmonier Nicolas   Marron Marilyn   Zeng Yi   Cantrell Jessica   Romanoski Angela   Sepassi Marjan   Thompson Sylvia   Chen Xinchun   Andreansky Samita   Katsanis Emmanuel  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 1, 2007-01 ,pp. : 48-59

Springer Publishing Company

Access to resources Recommend Favorite